OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5
Gustavo Lenci Marques, Shirley Yumi Hayashi, Anna Bjällmark, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 25

Showing 25 citing articles:

Inflammation and gut dysbiosis as drivers of CKD–MBD
Pieter Evenepoel, Peter Stenvinkel, Catherine M. Shanahan, et al.
Nature Reviews Nephrology (2023) Vol. 19, Iss. 10, pp. 646-657
Closed Access | Times Cited: 26

Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications
Rupinder Kaur, Ravinder Singh
Life Sciences (2022) Vol. 311, pp. 121148-121148
Closed Access | Times Cited: 30

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Mieczysław Dutka, Rafał Bobiński, Wojciech Wojakowski, et al.
Heart Failure Reviews (2021) Vol. 27, Iss. 4, pp. 1395-1411
Open Access | Times Cited: 37

The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods
Marcin Basiak, Marcin Hachuła, Michał Kosowski, et al.
Molecules (2023) Vol. 28, Iss. 15, pp. 5928-5928
Open Access | Times Cited: 12

Bone-derived factors mediate crosstalk between skeletal and extra-skeletal organs
Tailin He, Lei Qin, Sheng Chen, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access

Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality
Joanna Kamińska, Marek Stopiński, Krzysztof Mucha, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2413-2420
Open Access | Times Cited: 25

Pathophysiology and Clinical Impacts of Chronic Kidney Disease on Coronary Artery Calcification
Zhuoming Dai, Xiangyu Zhang
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 5, pp. 207-207
Open Access | Times Cited: 10

Association of mineral and bone biomarkers with adverse cardiovascular outcomes and mortality in the German Chronic Kidney Disease (GCKD) cohort
Katharina C. Reimer, Jennifer Nadal, Heike Meiselbach, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 8

Prognostic Role of Osteoprotegerin and Risk of Coronary Artery Calcification: A Systematic Review and Meta-Analysis
Sara Samadi, Masoumeh Sadeghi, Reza Javidi Dashtbayaz, et al.
Biomarkers in Medicine (2023) Vol. 17, Iss. 3, pp. 171-180
Closed Access | Times Cited: 6

Biomolecules Orchestrating Cardiovascular Calcification
Yin Tintut, Henry M. Honda, Linda L. Demer
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1482-1482
Open Access | Times Cited: 14

Osteoprotegerin Is a Better Predictor for Cardiovascular and All-Cause Mortality than Vascular Calcifications in a Multicenter Cohort of Patients on Peritoneal Dialysis
Marcela Ávila, Ma. del Carmen Prado, Renata Romero, et al.
Biomolecules (2022) Vol. 12, Iss. 4, pp. 551-551
Open Access | Times Cited: 9

Association of Serum Osteoprotegerin Level With Myocardial Injury and Cardiovascular Calcification in Chronic Kidney Disease Patients
Kamal Okasha, Mohamed Hussein Aboufreikha, Waleed Elrefaey, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6

Editorial: Management of osteoporosis in patients with chronic kidney disease
Mohamed Abdalbary, Mahmoud Sobh, Eman Nagy, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 2

Arterial calcifications and osteoprotegerin in chronic hemodialysis patients: impact on 6-year survival
Diana Moldovan, Crina Claudia Rusu, Alina Potra, et al.
International Urology and Nephrology (2021) Vol. 54, Iss. 5, pp. 1135-1143
Closed Access | Times Cited: 5

Impact of bisphenol a on the levels of vascular calcification biomarkers in type 2 diabetes mellitus with vascular complications: A case-control study
Mohanraj Nehru, Prasanth Subramaniam, M.S. Jancy, et al.
Emerging contaminants (2024) Vol. 10, Iss. 4, pp. 100342-100342
Open Access

Osteoprotegerin (OPG): A potential biomarker for adverse cardiovascular events in stable coronary artery disease
Syed Muhammad Muneeb Akhtar, Azzam Ali, Areeba Fareed, et al.
Health Science Reports (2024) Vol. 7, Iss. 7
Open Access

Analysis of angiotensin II type 1 receptor and osteoprotegerin gene polymorphism on the risk of cardiovascular mortality risk and progressivity of chronic kidney disease
Hendri Susilo, Budi Susetyo Pikir, Nathanael Jonathan Tjipta, et al.
Minerva Medica (2024) Vol. 115, Iss. 4
Closed Access

An antibody nanopore-enabled microsensor for detection of osteoprotegerin
Silu Feng, Qinglong Luo, Xin Song
Japanese Journal of Applied Physics (2024) Vol. 63, Iss. 11, pp. 117001-117001
Closed Access

Role of Uremic Toxins in Vascular Inflammation Associated with Chronic Kidney Disease
Rania Chermiti, Stéphane Burtey, Laetitia Dou
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7149-7149
Open Access

Association of Circulating Osteoprotegerin Level with Blood Pressure Variability in Patients with Chronic Kidney Disease
Sang Heon Suh, Tae Ryom Oh, Hong Sang Choi, et al.
Journal of Clinical Medicine (2021) Vol. 11, Iss. 1, pp. 178-178
Open Access | Times Cited: 3

Kidney Disease as Risk of In-Hospital Mortality in Patients With Acute Coronary Syndrome
Gustavo Lenci Marques, Noessa Hiromi Assano Stangler, Heloísa Ferro, et al.
Cureus (2021)
Open Access | Times Cited: 1

Page 1

Scroll to top